Research Bio
Dr. Hicks' first research interest was in bone pathology. He received NIH funding to study the effects of lead on the epiphyseal plate, and collaborated on related studies with faculty in the Department of Orthopaedics at the University of Rochester. He published extensively on metabolic and neoplastic bone disorders. While Director of Surgical Pathology and Co-director of the Morphologic Molecular Pathology translation research resource at the Cleveland Clinic, he expanded his interests in breast pathology, with particular focus on prognostic molecular markers and development of advanced tissue-based diagnostic techniques.
His current clinical translational research interests focus on molecular risk factors for breast cancer and preanalytical variables that affect the accuracy of new diagnostic technology in surgical pathology.
| Dr. Edith E. Sproul Teaching Award | Pathology, Roswell Park Cancer Institute |
2006 |
| John Beach Hazard Distinguished Teaching Award | Pathology, Cleveland Clinic Foundation |
2002 |
| Duthie-Evarts Education Award | Dept of Orthopaedics, URMC |
1997 |
| Andrew W. Mellon Dean's Teaching Scholar | University of Rochester |
1996 - 1999 |
| Kappa Delta Elizabeth Winston Lanier Award for Outstanding Orthopaedic Research | American Academy of Orthopaedic Surgeons |
1995 |
| Certificate of Commendation for Excellence in Medical Student Teaching | University of Rochester |
1993 |
| Arthur Purdy Stout Award | US and Canadian Academy of Pathology |
1991 |
| Stowell-Orbison Award | US and Canadian Academy of Pathology |
1989 |
| Award in Honor of George H. Whipple, M.D. | Rochester Academy of Medicine |
1984 |
| Member, Alpha Omega Alpha |
1984 |
| Robert Katz Award for Clinical Research Excellence | University of Rochester |
1984 |
2013 May
Hicks D, Whitney-Miller C. "The evolving role of HER2 evaluation for diagnosis and clinical decision making for breast and gastric adenocarcinoma." Biotechnic & histochemistry : official publication of the
Biological Stain Commission. 2013 May 0; 88(3-4):121-31. Epub 2013 Jan 07. |
2013 Jan
Potts SJ, Huff SE, Lange H, Zakharov V, Eberhard DA, Krueger JS, Hicks DG, Young GD, Johnson T, Whitney-Miller CL. "Tissue pattern recognition error rates and tumor heterogeneity in gastric cancer." Applied immunohistochemistry & molecular morphology : AIMM /
official publication of the Society for Applied Immunohistochemistry. 2013 Jan 0; 21(1):21-30. |
2013 Jan
Portier BP, Wang Z, Downs-Kelly E, Rowe JJ, Patil D, Lanigan C, Budd GT, Hicks DG, Rimm DL, Tubbs RR. "Delay to formalin fixation 'cold ischemia time': effect on ERBB2 detection by in-situ hybridization and immunohistochemistry." Modern pathology : an official journal of the United States and
Canadian Academy of Pathology, Inc. 2013 Jan 0; 26(1):1-9. Epub 2012 Aug 17. |
2012 Nov
Miyamoto H, Izumi K, Yao JL, Li Y, Yang Q, McMahon LA, Gonzalez-Roibon N, Hicks DG, Tacha D, Netto GJ. "GATA binding protein 3 is down-regulated in bladder cancer yet strong expression is an independent predictor of poor prognosis in invasive tumor." Human pathology. 2012 Nov 0; 43(11):2033-40. Epub 2012 May 18. |
2012 Sep
Mahar T, Hicks DG. "Breast and Prostate Cancer in a BRCA2 Carrier." The breast journal. 2012 Sep 0; 18(5):511-3. Epub 2012 Aug 17. |
